The standard research protocol involves 300-500mcg daily
Unlike many peptides that require specific environmental conditions to maintain stability, BPC-157 research has demonstrated notable stability in various pH environments
Microdosing The microdosing approach uses much lower amounts, often 0.5 to 1.5 mg per dose, for specific applications like inflammation management
Unlike hormonal compounds, no post-cycle therapy is required and no rebound effects occur when discontinuing use
This study implies that maintaining iron homeostasis is essential for eliminating pathogenic Tfh cells, which may lead to a more effective treatment for SLE patients
Always consult a licensed healthcare provider before beginning any new injection, infusion or supplement program, especially if you have underlying health conditions or take prescription medications